Based on this and other findings that show Fgf21 induction in mouse models of frontotemporal dementia (FTD) and prion disease, Fgf21 may be a suitable marker for neurodegenerative diseases that are accompanied by mitochondrial dysfunction (Restelli et al., 2018). This evidence concerns the gene FGF21 and prion disease.